Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Beta This is a new resource - your feedback will help us improve it. Learn More.

Corporate Integrity Agreement with Aegerion Pharmaceuticals, Inc., Amryt Pharma PLC

Closed  |  Effective from to  |  Duration 5 years
Location
Cambridge, MA
Settlement Amount
$28,800,000

AGREEMENT PRESS RELEASE

Drug Maker Aegerion Agrees to Plead Guilty; Will Pay More Than $35 Million to Resolve Criminal Charges and Civil False Claims Allegations

Published by the United States Department of Justice | View article on www.justice.gov

Aegerion Pharmaceuticals Inc., a Cambridge, Massachusetts-based subsidiary of Novelion Therapeutics Inc., has agreed to plead guilty to charges relating to its prescription drug, Juxtapid, the Justice Department announced today.

Report Type
Corporate Integrity Agreement
Category
Other
Tags
Prescription Drug